Helena Earl

Has grant

Professor Emeritus of Clinical Cancer Medicine

University of Cambridge

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

ARTemis - Translational

Open Date: 2016-04-01

Close Date: 2019-03-01

Grant: Close

PARTNER

Open Date: 2016-04-01

Close Date: 2020-03-01

Grant: Close

International Rare Cancers Initiative – HGUS Study

Open Date: 2013-11-01

Close Date: 2017-11-01

Grant: Close

ARTemis

Open Date: 2009-04-01

Close Date: 2014-03-01

Grant: Close

ARTemis

Open Date: 2009-04-01

Close Date: 2014-03-01

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Daniel Rea

Professor of Medical Oncology

University of Birmingham

UNITED KINGDOM

View details

Janet Dunn

Professor of Clinical Trials and Head of Cancer trials

University of Warwick

UNITED KINGDOM

View details

Jeremy Braybrooke

Honorary Associate Professor

University of Bristol

UNITED KINGDOM

View details

Robert Stein

Professor of Breast Oncology

University College London

UNITED KINGDOM

View details

Pericles Foroglou

Associate Professor

Aristotle University of Thessaloniki

GREECE

View details

Diana M Eccles

University of Southampton

UNITED KINGDOM

View details

Jean Abraham

Professor of Precision Breast Cancer Medicine

University of Cambridge

UNITED KINGDOM

View details

Stuart McIntosh

Clinical Senior Lecturer in Surgical Oncology

The Queen's University Belfast

UNITED KINGDOM

View details

Robert Winqvist

Professor

University of Oulu

FINLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Helena Earl

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (13)

The PARTNER trial of neoadjuvant olaparib in triple-negative breast cancer.

Safe de-escalation of chemotherapy in HER2-positive early breast cancer.

The Lancet Breast Cancer Commission

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.

The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge

Magnetization transfer imaging of ovarian cancer: initial experiences of correlation with tissue cellularity and changes following neoadjuvant chemotherapy.

Multi-omic machine learning predictor of breast cancer therapy response.

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.

Profiteering from vaccine inequity: nudge pharma towards "doing well by doing good".

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.

Collaborators (9)

Daniel Rea

Janet Dunn

Jeremy Braybrooke

Robert Stein

Pericles Foroglou

Diana M Eccles

Jean Abraham

Stuart McIntosh

Robert Winqvist

Make your next move.